Time course of chronic diazepam effects on the auditory evoked potential of the rat. 1998

M L Jongsma, and C M Van Rijn, and E A De Bruin, and R Dirksen, and A M Coenen
NICI, Department of Experimental Anesthesiology, University of Nijmegen, The Netherlands.

The time course of chronic diazepam effects on auditory evoked potentials was studied in rats. Auditory evoked potentials were elicited by background and target tones in a passive oddball paradigm. Diazepam was administered by slow release implants to establish constant blood concentrations. Recordings were made during 21 days of treatment and 9 days after treatment ceased. Diazepam increased the amplitude of the P40 component and decreased the amplitude of the P72-P102 components elicited by background tones. Diazepam increased the amplitude of the P40-P48 component and decreased that of the N58 component elicited by target tones. These effects remained constant during treatment. Diazepam further decreased the amplitude of the P102 component elicited by target tones. This effect became more distinct over time. No group differences were found 9 days after treatment. The constant drug effects on middle-latency components (P40-P48) might reflect diazepam-induced changes in sensory information processing. The decreased long-latency component (P102) might reflect a diminished attention to, or discrimination of, target tones. The time course of this effect might reflect diazepam-enhanced habituation.

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D008297 Male Males
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005072 Evoked Potentials, Auditory The electric response evoked in the CEREBRAL CORTEX by ACOUSTIC STIMULATION or stimulation of the AUDITORY PATHWAYS. Auditory Evoked Potentials,Auditory Evoked Response,Auditory Evoked Potential,Auditory Evoked Responses,Evoked Potential, Auditory,Evoked Response, Auditory,Evoked Responses, Auditory,Potentials, Auditory Evoked
D006185 Habituation, Psychophysiologic The disappearance of responsiveness to a repeated stimulation. It does not include drug habituation. Habituation (Psychophysiology),Habituation, Psychophysiological,Psychophysiologic Habituation,Psychophysiological Habituation,Habituations (Psychophysiology)
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

M L Jongsma, and C M Van Rijn, and E A De Bruin, and R Dirksen, and A M Coenen
June 1968, Journal of speech and hearing research,
M L Jongsma, and C M Van Rijn, and E A De Bruin, and R Dirksen, and A M Coenen
June 1990, Neuropharmacology,
M L Jongsma, and C M Van Rijn, and E A De Bruin, and R Dirksen, and A M Coenen
January 2002, Journal of vestibular research : equilibrium & orientation,
M L Jongsma, and C M Van Rijn, and E A De Bruin, and R Dirksen, and A M Coenen
November 2008, Journal of psychopharmacology (Oxford, England),
M L Jongsma, and C M Van Rijn, and E A De Bruin, and R Dirksen, and A M Coenen
January 1987, Experimental brain research,
M L Jongsma, and C M Van Rijn, and E A De Bruin, and R Dirksen, and A M Coenen
April 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
M L Jongsma, and C M Van Rijn, and E A De Bruin, and R Dirksen, and A M Coenen
January 1988, Electroencephalography and clinical neurophysiology,
M L Jongsma, and C M Van Rijn, and E A De Bruin, and R Dirksen, and A M Coenen
June 1999, Journal of speech, language, and hearing research : JSLHR,
M L Jongsma, and C M Van Rijn, and E A De Bruin, and R Dirksen, and A M Coenen
January 1988, Progress in neurobiology,
M L Jongsma, and C M Van Rijn, and E A De Bruin, and R Dirksen, and A M Coenen
September 1988, Experimental neurology,
Copied contents to your clipboard!